Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senseonics
MedTech
FDA clears Senseonics' 365-day Eversense CGM implant
Developed by Senseonics and Ascensia Diabetes Care, the Eversense 365 implant got the go-ahead for adults with Type 1 or Type 2 diabetes.
Conor Hale
Sep 17, 2024 11:00am
Ascensia completes European launch of Eversense 6-month CGM
Oct 10, 2022 10:22am
Senseonics' 180-day glucose sensor scores new European approval
Jun 16, 2022 11:55am
Ascensia Diabetes Care launches Eversense's 6-month CGM system
Apr 4, 2022 10:45am
Senseonics lands long-awaited FDA OK for 6-month CGM implant
Feb 11, 2022 9:42am
The top 10 Fierce Medtech stories of 2021
Dec 23, 2021 5:00am
